Academic literature on the topic 'Hodgkin lymphoma'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hodgkin lymphoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hodgkin lymphoma"

1

Mugabe Byiringiro, Fiacre, Felix Manirakiza, Déogratias Ruhangaza, Thierry Zawadi Muvunyi, and Belson Rugwizangoga. "Pathology Characteristics of Lymphomas in Rwanda: A Retrospective Study." East African Health Research Journal 5, no. 2 (2021): 170–73. http://dx.doi.org/10.24248/eahrj.v5i2.669.

Full text
Abstract:
Background: Lymphomas have been a global challenge for many decades and despite measures for prevention and management, the incidence continues to increase. There are two main categories, which are Non-Hodgkin’s Lymphomas and Hodgkin’s Lymphomas and most common etiologies are environmental, genetic alteration, radiation and some viruses. Objective: To describe pathology characteristics of lymphomas in Rwanda based on Hematoxylin and Eosin stained glass slides and immuno histo chemistry, and classify them according to clinical aggressiveness. Patients and Methods: We conducted a retrospective o
APA, Harvard, Vancouver, ISO, and other styles
2

Singh, Vikram, Pratiksha Hada, Sakshi Sharma, and Shivam Dubey. "Intraoral Swelling: A Rare Case Report with Diagnostic Perplexity." Journal of Indian Academy of Oral Medicine and Radiology 36, no. 2 (2024): 181–83. https://doi.org/10.4103/jiaomr.jiaomr_167_23.

Full text
Abstract:
Abstract Non-Hodgkin lymphomas are malignant tumor that arises from the lymphoreticular system. Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma distinguished by the proliferation of pleomorphic large lymphoid cells expressing CD30 antigen. This case report is about a 55-year-old patient who had pain and swelling in her lower front teeth region. The immunohistochemistry report confirmed the diagnosis of high-grade non-Hodgkin’s lymphoma of the anaplastic null cell type.
APA, Harvard, Vancouver, ISO, and other styles
3

Manzella, Adonis, Paulo Borba-Filho, Giuseppe D'Ippolito, and Marcella Farias. "Abdominal Manifestations of Lymphoma: Spectrum of Imaging Features." ISRN Radiology 2013 (September 2, 2013): 1–11. http://dx.doi.org/10.5402/2013/483069.

Full text
Abstract:
Non-Hodgkin and Hodgkin lymphomas frequently involve many structures in the abdomen and pelvis. Extranodal disease is more common with Non-Hodgkin’s lymphoma than with Hodgkin's lymphoma. Though it may be part of a systemic lymphoma, single onset of nodal lymphoma is not rare. Extranodal lymphoma has been described in virtually every organ and tissue. In decreasing order of frequency, the spleen, liver, gastrointestinal tract, pancreas, abdominal wall, genitourinary tract, adrenal, peritoneal cavity, and biliary tract are involved. The purpose of this review is to discuss and illustrate the sp
APA, Harvard, Vancouver, ISO, and other styles
4

Ahmed, Mahtab Uddin, and Harun-Or-Rashid Khan Shilpi. "Significance of Immunohistochemistry in Accurate Characterisation of Hodgkin Lymphoma." Journal of Enam Medical College 5, no. 1 (2015): 23–29. http://dx.doi.org/10.3329/jemc.v5i1.21493.

Full text
Abstract:
Background: Hodgkin lymphomas are malignant disorders of cells residing in lymphoid tissue and containing Reed-Sternberg (RS) cells and its variants and account for about 0.7% of all new cancers. Hodgkin lymphomas are two types: Classical Hodgkin lymphoma (CHL) that is CD30 positive and CD45 negative in specific pattern; Lymphocyte-predominant Hodgkin lymphoma (LPHL) that is CD30 negative and CD45 positive in specific pattern. Objective: To evaluate the value of immunohistochemistry in the diagnosis and accurate characterisation of Hodgkin lymphoma. Materials and Methods: This cross-sectional
APA, Harvard, Vancouver, ISO, and other styles
5

Montes-Moreno, S. "Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment." Advances in Hematology 2011 (2011): 1–6. http://dx.doi.org/10.1155/2011/142395.

Full text
Abstract:
Thomas Hodgkin's and Samuel Wilks first recognized Hodgkin disease in the first half of the 19th century. Initially described as lymphogranulomatosis, it was later recognized to be a lymphoid neoplasm derived from B cells and was classified on the basis of its histopathological features. Hodgkin lymphomas are now regarded as encompassing two clearly defined entities according to the WHO classification: nodular lymphocyte-predominant Hodgkin Lymphoma (NLPHL) and classical Hodgkin Lymphoma (CHL). This paper focuses on the current knowledge about the biological features that characterize both NLP
APA, Harvard, Vancouver, ISO, and other styles
6

Yadav, Geeta, Anurag Singh, Mili Jain, Rashmi Kushwaha, and Shailendra Prasad Verma. "Reed Sternberg-Like Cells in Non-Hodgkin Lymphoma: A Diagnostic Challenge." Discoveries 10, no. 3 (2022): e155. http://dx.doi.org/10.15190/d.2022.14.

Full text
Abstract:
Reed-Sternberg cells are distinguishing features of classical Hodgkin lymphoma. However, they are seen infrequently, in both B and T cells NonHodgkin lymphomas with a comparable morphology and immunophenotype. These cells are known as Reed-Sternberg-like cells. The characteristic background milieu of classical Hodgkin lymphoma is typically not present in Non-Hodgkin lymphomas, and Reed-Sternberg-like cells are typically present as dispersed cells or in tiny clusters. They are positive for CD30, show variable expression of B cell lineage markers and are negative for CD45/LCA in Non-Hodgkin lymp
APA, Harvard, Vancouver, ISO, and other styles
7

Sumoza, Luis D., Jeffrey L. Jorgensen, and Ilia R. Sumoza. "Composite Nodular Sclerosis Hodgkin and Diffuse Large B Cell Non-Hodgkin Lymphoma Arising from the Thymus." Blood 110, no. 11 (2007): 4432. http://dx.doi.org/10.1182/blood.v110.11.4432.4432.

Full text
Abstract:
Abstract We report the first case of composite Nodular Sclerosis Hodgkin and Diffuse Large B-Cell Non-hodgkin’s lymphoma of the mediastinum. We present a case of an inmunocompetent patient operated on for a mediastinal tumor similar to a Thymoma, which the histological examination morphological, and immunophenotyping were performed and confirmed the existence of 2 independent, unrelated tumors. The pathology blocks submitted show a composite lymphoma, with components of both classical Hodgkin lymphoma (Hodgkin’s disease), nodular sclerosis type, grade 2 of 2 in all three blocks. One block also
APA, Harvard, Vancouver, ISO, and other styles
8

Ahn, Ji Yong. "Gastrointestinal Tract Lymphoma." Korean Journal of Helicobacter and Upper Gastrointestinal Research 22, no. 1 (2022): 18–28. http://dx.doi.org/10.7704/kjhugr.2021.0064.

Full text
Abstract:
The gastrointestinal tract is the most common site of extranodal lymphoma, and more than 95% of gastrointestinal lymphoma cases are of the non-Hodgkin type. The stomach is the primary site of extranodal non-Hodgkin lymphoma, and more than 98% of primary gastric lymphoma (PGL) cases are diffuse large B-cell lymphomas (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphomas. Because PGL usually presents with nonspecific clinical symptoms and various endoscopic features, its diagnosis is mainly dependent on histopathologic findings. Chemotherapy is the first-line treatment choice for gastri
APA, Harvard, Vancouver, ISO, and other styles
9

Bansal, Rimpi, Puneet Kaur, Jatin Sarin, Anureet Kaur, and Akshita Sarin. "Incidence and Prognostic Implication of Bone Marrow Involvement in Hodgkin’s Lymphoma." Annals of Pathology and Laboratory Medicine 8, no. 11 (2021): A239–242. http://dx.doi.org/10.21276/apalm.3010.

Full text
Abstract:
Introduction- : Conducting Bone marrow examination in a Hodgkin's Lymphoma (HL) patient at the time of diagnosis is done routinely to determine the stage of the disease. The aim of this study was to analyze the incidence and prognosis of bone marrow involvement in patients with Hodgkins lymphoma, retrospectively.
 Materials and Patients: Ten patients of Hodgkins lymphoma were incorporated in the current study. Bone marrow aspiration and biopsy was done in all ten cases as part of staging procedure.
 Results: Three patients showed involvement of bone marrow by Hodgkin’s lymphoma and b
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Ling, Yaling Yang, C. Cameron Yin, et al. "Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma." Blood 118, no. 21 (2011): 4633. http://dx.doi.org/10.1182/blood.v118.21.4633.4633.

Full text
Abstract:
Abstract Abstract 4633 Background: Golgins are proteins of the Golgi complex. Several Golgins have been implicated in apoptosis. Expression of Golgin-84, a Golgin protein, is altered in apoptotic WEHI-231, a B-cell lymphoma line, suggesting that Golgin-84 may play a role in lymphoid tumorigenesis. Here, we aimed to determine the expression levels of Golgin-84 in human primary non-Hodgkin lymphomas and plasma cell myeloma. Design: Golgin-84 expression was investigated in non-Hodgkin lymphoma cell lines by using Western blot analysis and polyclonal antibodies. Using immunohistochemical stains, W
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hodgkin lymphoma"

1

Busson, Raphaël. "Fatigue chronique chez les survivants d'un lymphome." Thesis, Normandie, 2018. http://www.theses.fr/2018NORMC238/document.

Full text
Abstract:
La progression des traitements dans le lymphome amène à s’intéresser à la qualité de vie des survivants. La fatigue chronique est le problème le plus fréquemment décrit par les survivant. Dans le cadre du lymphome hodgkinien, le niveau de fatigue revêt une importance particulière par les patients ont entre 20 et 40 ans et sont confronté aux problématiques de retour à l’emploi. Dans la première partie de cette thèse, nous traiterons des causes de la fatigue et de sont évolutions pour les lymphomes hodgkinien et les lymphomes non-hodgkinien. En particulier, nous mettrons en lumière l’impacte des
APA, Harvard, Vancouver, ISO, and other styles
2

Majeed, Aneela, Onyee Chan, Onyemaechi Okolo, Volodymyr Shponka, Anca Georgescu, and Daniel Persky. "Hodgkin Lymphoma Mimicking Osteomyelitis." KARGER, 2017. http://hdl.handle.net/10150/625840.

Full text
Abstract:
Hodgkin lymphoma with symptomatic osseous involvement can have a similar presentation to osteomyelitis. Common findings in symptoms, laboratory workup, and imaging can make it very difficult to distinguish between the two diseases. Excisional biopsy should be pursued if fine-needle biopsy is equivocal and suspicion of lymphoma is high. We report a case of a 40-year-old man who presented with a history of marine animal sting on his neck and later developed erythema in the area, chest pain, constitutional symptoms, adenopathy, and imaging classic for sternal osteomyelitis. Fortunately, initial b
APA, Harvard, Vancouver, ISO, and other styles
3

Amini, Rose-Marie. "Hodgkin Lymphoma : Studies of Advanced Stages, Relapses and the Relation to Non-Hodgkin Lymphomas." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2002. http://publications.uu.se/theses/91-554-5265-5/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cuceu, Corina. "Telomere Dysfunction And Chromosomal Instability In Hodgkin Lymphoma." Thesis, Université Paris-Saclay (ComUE), 2015. http://www.theses.fr/2015SACLS210/document.

Full text
Abstract:
Le lymphome de Hodgkin est caractérisé, d’un point de vue histologique, par la présence de rares cellules tumorales nommées cellules de Reed et Sternberg, au sein d’un infiltrat cellulaire polymorphe, inflammatoire et réactionnel. Cette dernière résulte de la transformation tumorale de cellules lymphocytaires B qui acquièrent des propriétés d’échappement au système immun, de prolifération, de résistance à l’apoptose et une instabilité chromosomique. Néanmoins, la rareté des cellules tumorales, impliquant des problèmes techniques mais aussi de caractérisation des évènements primaires dans l’ini
APA, Harvard, Vancouver, ISO, and other styles
5

Ferreira, Filho José Laurentino 1990. "Relation between digit ratio (2D:4D) and Hodgkin's lymphoma." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/287812.

Full text
Abstract:
Orientador: Jacks Jorge Junior<br>Texto em português e inglês<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba<br>Made available in DSpace on 2018-08-25T06:56:55Z (GMT). No. of bitstreams: 1 FerreiraFilho_JoseLaurentino_M.pdf: 1327041 bytes, checksum: 2b08a1dcef02da5393c3fdad74be531f (MD5) Previous issue date: 2014<br>Resumo: Estudos sugerem que a proporção digital pode ser utilizada como marcador putativo para a exposição pré-natal a hormônios sexuais e como marcador da expressão de genes HOX. Genes homeobox controlam a organogênese e a f
APA, Harvard, Vancouver, ISO, and other styles
6

Molin, Daniel. "Bystander Cells and Prognosis in Hodgkin Lymphoma." Doctoral thesis, Uppsala University, Department of Oncology, Radiology and Clinical Immunology, 2002. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2547.

Full text
Abstract:
<p>Hodgkin lymphoma (HL) is characterised histologically by a minority of malignant Hodgkin and Reed-Sternberg (HRS) cells surrounded by benign cells, and clinically by a relatively good prognosis. The treatment, however, leads to a risk of serious side effects. Knowledge about the biology of the disease, particularly the interaction between the HRS cells and the surrounding cells, is essential in order to improve diagnosis and treatment. </p><p>HL patients with abundant eosinophils in the tumours have a poor prognosis, therefore the eosinophil derived protein eosinophil cationic protein (ECP)
APA, Harvard, Vancouver, ISO, and other styles
7

Bley, Linda D. "Nutritional factors and non-Hodgkin's Lymphoma /." Thesis, Connect to this title online; UW restricted, 1996. http://hdl.handle.net/1773/10864.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bur, H. (Hamid). "Biological prognostic and predictive markers in Hodgkin lymphoma." Doctoral thesis, Oulun yliopisto, 2018. http://urn.fi/urn:isbn:9789526219455.

Full text
Abstract:
Abstract Hodgkin lymphoma (HL) is among a heterogeneous group of lymphomas. Over 80% of all patients can be cured with chemo- and radiotherapy. HL has become a model to study long-term effects of radio- and chemotherapy, because of the excellent prognosis. There are a significant number of patients who suffer or die because of the treatment-related long-term toxicity. The aim of this work was to discover new possible biological factors to predict poor prognosis and offer new aspects to individualize patient treatment in a convenient manner in HL. The retrospective study involved HL patients un
APA, Harvard, Vancouver, ISO, and other styles
9

Englund, Annika. "Hodgkin Lymphoma in children, adolescents and young adults." Doctoral thesis, Uppsala universitet, Institutionen för kvinnors och barns hälsa, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-316796.

Full text
Abstract:
Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site to a widespread condition. The prognosis with contemporary treatment is excellent for the vast majority. However, the treatment might cause severe late adverse effects in a proportion of the affected individuals. We evaluated all children and adolescents diagnosed in Sweden and registered in the Swedish Childhood Cancer Register over a period of 25 years. The incidence has been stable and the overall survival (OS) is very good, comparable to the best results in the world. Approximately ten perce
APA, Harvard, Vancouver, ISO, and other styles
10

Aleman, Berthe Mauricia Pauline. "Optimizing treatment of patients with Hodgkin's lymphoma." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2007. http://dare.uva.nl/document/43623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hodgkin lymphoma"

1

R, Hoppe, ed. Hodgkin lymphoma. 2nd ed. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Engert, Andreas, and Sandra J. Horning, eds. Hodgkin Lymphoma. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-12780-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Engert, Andreas, and Anas Younes, eds. Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-12505-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Engert, Andreas, and Anas Younes, eds. Hodgkin Lymphoma. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-32482-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

1946-, Armitage James O., ed. Non-Hodgkin lymphomas. 2nd ed. Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1946-, Armitage James O., ed. Non-Hodgkin lymphomas. 2nd ed. Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ian, Magrath, ed. The non-Hodgkin's lymphomas. 2nd ed. Arnold, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Quesenberry, Peter J., and Jorge J. Castillo, eds. Non-Hodgkin Lymphoma. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-5851-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Evens, Andrew M., and Kristie A. Blum, eds. Non-Hodgkin Lymphoma. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13150-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Specht, Lena, and Joachim Yahalom, eds. Radiotherapy for Hodgkin Lymphoma. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-540-78944-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hodgkin lymphoma"

1

Kirsch, Brian James, Shu-Jyuan Chang, Michael James Betenbaugh, and Anne Le. "Non-Hodgkin Lymphoma Metabolism." In The Heterogeneity of Cancer Metabolism. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_7.

Full text
Abstract:
AbstractNon-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with different biological characteristics. About 90% of all lymphomas in the United States originate from B lymphocytes, while the remaining originate from T cells [1]. The treatment of NHLs depends on the neoplastic histology and stage of the tumor, which will indicate whether radiotherapy, chemotherapy, or a combination is the best suitable treatment [2]. The American Cancer Society describes the staging of lymphoma as follows: Stage I is lymphoma in a single node or area. Stage II is when that lymphoma has
APA, Harvard, Vancouver, ISO, and other styles
2

Glaser, Sally L., Ellen T. Chang, Christina A. Clarke, and Theresa H. Keegan. "Epidemiology." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Johnson, Peter, and David Straus. "Principles of Chemotherapy in Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lugtenburg, Pieternella, and Anton Hagenbeek. "Treatment of Early Favorable Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Raemaekers, John M. M., and Andreas Engert. "Treatment of Early Unfavorable HL." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Borchmann, Peter, Massimo Federico, and Volker Diehl. "Treatment of Advanced-Stage Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hall, Georgina W., Cindy L. Schwartz, Stephen Daw, and Louis S. Constine. "Pediatric Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Böll, Boris, and Andrew M. Evens. "The Management of Older Patients with Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Eichenauer, Dennis A., and Michelle A. Fanale. "Nodular Lymphocyte-Predominant Hodgkin Lymphoma." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bachanova, Veronika, and Joseph M. Connors. "The Management of Hodgkin Lymphoma During Pregnancy." In Hodgkin Lymphoma. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12505-3_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hodgkin lymphoma"

1

Delgertsetseg, D. "Hodgkin Lymphoma Cases in Mongolia." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701856.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Giulino-Roth, Lisa G. "Abstract IA09: Genomics of common AYA lymphomas: Hodgkin lymphoma and primary mediastinal B-cell lymphoma." In Abstracts: AACR Virtual Meeting: Advances in Malignant Lymphoma; August 17-19, 2020. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2643-3249.lymphoma20-ia09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Henderson, TO. "Navigating Survivorship for AYAs with Hodgkin Lymphoma." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701943.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Volchenboum, SL. "Creating an International Hodgkin Lymphoma Data Commons." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Delasos, L. "Hodgkin Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: Subtype Matters." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6518.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

ROSA, RAFAELLA GAYA, ADIR CARDOSO GENTIL, ANA PAULA PUSCH, CAMILA MARCHI BLATT, and GUILHERME FERREIRA ZONTA. "PANUVEITIS AS A MANIFESTATION OF HODGKIN LYMPHOMA." In 36º Congresso Brasileiro de Reumatologia. Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-196.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pinto, Thales Ponsá, Natália Cirino Talim, Paulo Pereira Christo, et al. "Understanding Hodgkin lymphoma occurrence after fingolimod withdrawal." In 25th BCTRIMS Annual Meeting. Thieme Revinter Publicações Ltda., 2024. http://dx.doi.org/10.1055/s-0044-1789397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Caliari, Vitória de Ataide, Herika Negri, Claudio vidal, Bruno lobo, Dhyego lacerda, and Débora de Moura Muniz. "Primary Central Nervous System Lymphoma of the Posterior Fossa in Immunocompetent Patient: A Case Report and Review of Literature." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.025.

Full text
Abstract:
Context: Primary central nervous system lymphomas (PCNSL) are a rare but very aggressive subtype of extranodal non-Hodgkin lymphomas. They represent only 4% of primary central nervous system lesions and are more common in patients with aggressive non-Hodgkin lymphomas, who are HIV positive. Moreover, PCNSL, usually presents as intraparenchymal supratentorial expansive lesions, while secondary CNS lymphomas tend to present as metastases in the leptomeninges. Although they are more common in immunocompromised patients, their incidence has increased with advancing age. Due to its uniqueness in fi
APA, Harvard, Vancouver, ISO, and other styles
9

Ramayanam, S., M. S. Godfrey, and J. Puchalski. "Primary Pulmonary Hodgkin Lymphoma Masquerading as Chronic Infection." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5872.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Klekawka, T., A. Moryl-Bujakowska, K. Smalisz, et al. "Nodular Lymphocyte Predominant Hodgkin Lymphoma - experience of Polish Pediatric Leukemia/Lymphoma Study Group." In ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701854.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hodgkin lymphoma"

1

Cozen, Wendy, Victoria Cortessis, David Conti, et al. Immune Response Genotypes and Risk of Young Adult Hodgkin Lymphoma. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada484349.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Popova, Tsvetelina Kostadinova, Liliya Ivanova, Ivaylo Hristov та ін. Detection of Еpstein‑Barr Virus DNA in Patients with Hodgkin Lymphoma. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2021. http://dx.doi.org/10.7546/crabs.2021.09.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Lin, Feng Jin, and Hua Fan. Metabolic tumor volume and survival of Non-Hodgkin lymphoma on CAR-T. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wang, Jinjin. Efficacy and safety of copanlisib in relapse/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mao, Qiyuan, Lanchun Liu, Xueqian Wang, et al. Compound Kushen injection combined with chemotherapy for patients with non-Hodgkin lymphoma: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.2.0063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhu, XiuLi, YuQiao Diao, and Yan Chen. Efficacy and Safety of Rituximab Combined with Chemotherapy Regimen in Children and Adolescents with Mature B-Cell Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.2.0120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rituximab helps cure almost all children with non-Hodgkin’s lymphoma. National Institute for Health Research, 2020. http://dx.doi.org/10.3310/alert_42831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!